200 related articles for article (PubMed ID: 27356668)
21. Lentivirus-mediated shRNA interference of clusterin blocks proliferation, motility, invasion and cell cycle in the ovarian cancer cells.
Fu Y; Lai Y; Liu J; Liu X; You Z; Yang G
J Ovarian Res; 2015 Aug; 8():59. PubMed ID: 26293319
[TBL] [Abstract][Full Text] [Related]
22. Expression of serine protease SNC19/matriptase and its inhibitor hepatocyte growth factor activator inhibitor type 1 in normal and malignant tissues of gastrointestinal tract.
Zeng L; Cao J; Zhang X
World J Gastroenterol; 2005 Oct; 11(39):6202-7. PubMed ID: 16273651
[TBL] [Abstract][Full Text] [Related]
23. Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo.
Oberst M; Anders J; Xie B; Singh B; Ossandon M; Johnson M; Dickson RB; Lin CY
Am J Pathol; 2001 Apr; 158(4):1301-11. PubMed ID: 11290548
[TBL] [Abstract][Full Text] [Related]
24. NFATc1 regulates cell proliferation, migration, and invasion of ovarian cancer SKOV3 cells in vitro and in vivo.
Li L; Duan Z; Yu J; Dang HX
Oncol Rep; 2016 Aug; 36(2):918-28. PubMed ID: 27350254
[TBL] [Abstract][Full Text] [Related]
25. Targeting HMGB1 inhibits ovarian cancer growth and metastasis by lentivirus-mediated RNA interference.
Chen J; Liu X; Zhang J; Zhao Y
J Cell Physiol; 2012 Nov; 227(11):3629-38. PubMed ID: 22331597
[TBL] [Abstract][Full Text] [Related]
26. Fibulin-5 is a tumour suppressor inhibiting cell migration and invasion in ovarian cancer.
Heo JH; Song JY; Jeong JY; Kim G; Kim TH; Kang H; Kwon AY; An HJ
J Clin Pathol; 2016 Feb; 69(2):109-16. PubMed ID: 26251522
[TBL] [Abstract][Full Text] [Related]
27. [Inhibitory effect of antisense oligonucleotide of integrin-linked kinase on cell proliferation of human epithelial ovarian cancer].
Li Q; Zhang YH; Li PL; Pei JR
Zhonghua Fu Chan Ke Za Zhi; 2008 Mar; 43(3):218-22. PubMed ID: 18788574
[TBL] [Abstract][Full Text] [Related]
28. Differential subcellular localization renders HAI-2 a matriptase inhibitor in breast cancer cells but not in mammary epithelial cells.
Chang HH; Xu Y; Lai H; Yang X; Tseng CC; Lai YJ; Pan Y; Zhou E; Johnson MD; Wang JK; Lin CY
PLoS One; 2015; 10(3):e0120489. PubMed ID: 25786220
[TBL] [Abstract][Full Text] [Related]
29. TMPRSS3 modulates ovarian cancer cell proliferation, invasion and metastasis.
Zhang D; Qiu S; Wang Q; Zheng J
Oncol Rep; 2016 Jan; 35(1):81-8. PubMed ID: 26531004
[TBL] [Abstract][Full Text] [Related]
30. WAP four-disulfide core domain protein 2 mediates the proliferation of human ovarian cancer cells through the regulation of growth- and apoptosis-associated genes.
Chen Y; Mu X; Wang S; Zhao L; Wu Y; Li J; Li M
Oncol Rep; 2013 Jan; 29(1):288-96. PubMed ID: 23129262
[TBL] [Abstract][Full Text] [Related]
31. The combined effect of survivin-targeted shRNA and emodin on the proliferation and invasion of ovarian cancer cells.
Xue H; Chen Y; Cai X; Zhao L; He A; Guo K; Zheng X
Anticancer Drugs; 2013 Oct; 24(9):937-44. PubMed ID: 23921083
[TBL] [Abstract][Full Text] [Related]
32. Inactivation of serine protease Matriptase1a by its inhibitor Hai1 is required for epithelial integrity of the zebrafish epidermis.
Carney TJ; von der Hardt S; Sonntag C; Amsterdam A; Topczewski J; Hopkins N; Hammerschmidt M
Development; 2007 Oct; 134(19):3461-71. PubMed ID: 17728346
[TBL] [Abstract][Full Text] [Related]
33. [Effects of small interfering RNA specific to stably transfected HMGA1 gene on biological characters of ovarian carcinoma cells].
Liu YL; Zheng JH
Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):51-5. PubMed ID: 20367927
[TBL] [Abstract][Full Text] [Related]
34. A novel biomarker for staging human prostate adenocarcinoma: overexpression of matriptase with concomitant loss of its inhibitor, hepatocyte growth factor activator inhibitor-1.
Saleem M; Adhami VM; Zhong W; Longley BJ; Lin CY; Dickson RB; Reagan-Shaw S; Jarrard DF; Mukhtar H
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):217-27. PubMed ID: 16492908
[TBL] [Abstract][Full Text] [Related]
35. [Inhibitory effects of RNA interference on expression of matrix metalloproteinase-9 gene and invasiveness and adhesion in ovarian cancer cells].
Hu XX; Li L; Li DR; Zhang W; Tang BJ
Zhonghua Fu Chan Ke Za Zhi; 2006 Sep; 41(9):579-83. PubMed ID: 17181964
[TBL] [Abstract][Full Text] [Related]
36. The Long Noncoding RNA MALAT-1 Is Highly Expressed in Ovarian Cancer and Induces Cell Growth and Migration.
Zhou Y; Xu X; Lv H; Wen Q; Li J; Tan L; Li J; Sheng X
PLoS One; 2016; 11(5):e0155250. PubMed ID: 27227769
[TBL] [Abstract][Full Text] [Related]
37. Expression of hepatocyte growth factor activator inhibitors (HAI-1 and HAI-2) in ovarian cancer.
Nakamura K; Abarzua F; Kodama J; Hongo A; Nasu Y; Kumon H; Hiramatsu Y
Int J Oncol; 2009 Feb; 34(2):345-53. PubMed ID: 19148468
[TBL] [Abstract][Full Text] [Related]
38. CDKN3 knockdown reduces cell proliferation, invasion and promotes apoptosis in human ovarian cancer.
Zhang LP; Li WJ; Zhu YF; Huang SY; Fang SY; Shen L; Gao YL
Int J Clin Exp Pathol; 2015; 8(5):4535-44. PubMed ID: 26191143
[TBL] [Abstract][Full Text] [Related]
39. Hepatocyte growth factor activation inhibitors (HAI-1 and HAI-2) regulate HGF-induced invasion of human breast cancer cells.
Parr C; Jiang WG
Int J Cancer; 2006 Sep; 119(5):1176-83. PubMed ID: 16557597
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of integrin β1 decreases the malignancy of ovarian cancer cells and potentiates anticancer therapy via the FAK/STAT1 signaling pathway.
Zhang L; Zou W
Mol Med Rep; 2015 Dec; 12(6):7869-76. PubMed ID: 26497667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]